Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Vessel Dilation Device Advances Peripheral Artery Interventions

By HospiMedica International staff writers
Posted on 17 Mar 2017
A novel dilation balloon creates multiple longitudinal micro-serrations in order to help the expansion of blood vessels in peripheral artery disease (PAD).

The Cagent Vascular Serranator Alto combines mechanical percutaneous transluminal angioplasty (PTA) balloon dilatation and multiple serrated scoring elements in order to create linear, interrupted scoring along the endoluminal surface of peripheral arteries. More...
The teeth-like ridges are located on four sides of the dilation balloon; as it is pumped with saline to expand a constricted vessel, the ridges create tiny serrations lines help guide the expansion of the arteries.

The Serranator Alto is intended for dilatation of PAD lesions in the iliac, femoral, iliofemoral, and popliteal arteries, as well as for the treatment of obstructive lesions of native or synthetic arteriovenous (AV) dialysis fistulae. The need for the device, according to the company, arises from an increasingly aging population, increased incidence of obesity, type-2 diabetes, smoking, and hypercholesterolemia, all of which contribute to an increased lesion complexity in PDA.

“A new approach to vessel dilatation is long overdue for treatment of diseased peripheral arteries; today we are treating more complex lesions that require better tools,” said vascular surgeon Peter Schneider, MD, co-founder and chief medical officer of Cagent Vascular. “We believe serration technology will prove to be effective in more complex lesions and will evolve into the new standard of care for vessel dilatation. In the future we hope to show clinical benefit as a vessel preparation tool with new technologies, such as drug coated balloons.”

“We have also begun the development of the Serranator Bass for treatment of the below-the-knee or infrapopliteal arteries, where new technologies are desperately needed for the treatment of critical limb ischemia,” said Carol Burns, CEO of Cagent Vascular. “Future applications of interest include serration technology for vessel preparation prior to the use of bioresorbable scaffolds in coronary arteries.”

PAD results when the peripheral arteries become too narrow or obstructed due to plaque, limiting blood flow to the legs. If left untreated, it can cause pain or aching in the legs, difficulty with walking, resting pain in the foot at night while lying down, and non-healing sores or infections in the toes or feet; PAD can ultimately lead to limb loss in its most severe form. In addition, it can be associated with other serious arterial conditions that can lead to heart attacks and stroke.


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
New
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Gold Member
Blood Gas Analyzer
i-Check200
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: 123RF

AI Platform Screens for Amyloid Cardiomyopathy Using ECG Images

Amyloid cardiomyopathy is a heart disease caused by deposits of misfolded proteins in the cardiac muscle. It is often missed until patients develop serious complications such as heart failure.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.